MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells

Non-small cell lung cancers (NSCLCs) that harbor an oncogenic KRAS mutation are often associated with resistance to targeted therapies. The MUC1-C transmembrane protein is aberrantly overexpressed in NSCLCs and confers a poor outcome; however, the functional role for MUC1-C in mutant KRAS NSCLC cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Kharbanda, Akriti, Rajabi, Hasan, Jin, Caining, Alam, Maroof, Wong, Kwok-Kin, Kufe, Donald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253405/
https://www.ncbi.nlm.nih.gov/pubmed/25245423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253405/
https://www.ncbi.nlm.nih.gov/pubmed/25245423

Ejemplares similares